Holston Health Associates
Practical guidance and updates in psychiatry, addiction treatment, and obesity medicine — drawn from public health and professional sources.
Educational only. Tips & News summaries are for general information from public health and professional sources. They are not a diagnosis, treatment plan, or substitute for care from your own clinician. Medication or treatment changes should only be made with a qualified healthcare professional. If you are in crisis, call or text 988 (U.S.), or call 911 for a medical emergency.
Preparing for a visit can help you make the most of your time with a clinician. Consider listing your symptoms, questions, medications and supplements, and relevant family history. Noting when symptoms began, how often they occur, and any major stressors can help guide a conversation about treatment options that fit your goals.
National Institute of Mental Health (NIMH) · 2022 · NIH Publication No. 22-MH-8094Long-term benzodiazepine use can carry risks, including falls, cognitive effects, and overdose—especially when combined with opioids. Joint clinical guidance emphasizes that people who may be physically dependent should not stop suddenly. When risks outweigh benefits, a slow, individualized, monitored taper and shared decision-making are recommended.
American Society of Addiction Medicine (ASAM) · June 17, 2025The OMA’s 2026 algorithm frames obesity as a complex chronic disease, not a willpower problem. It supports a thorough assessment of medical history, related conditions, nutrition, activity, sleep, and behavior. Care is individualized and may include lifestyle counseling, medication, devices, or surgery when appropriate, with treatment plans revisited over time.
Obesity Medicine Association (OMA) · 2026 editionLooking for older updates?
Tips & News Archive